• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis.

作者信息

Ring J, Seifert J, Anstwurm H, Frick E, Mertin J, Brass B, Backmund H, Lob G

出版信息

Postgrad Med J. 1976;52(5 Suppl):123-30.

PMID:792844
Abstract

Twenty patients with multiple sclerosis, in whom treatment with azathioprine and steroids had not altered the progression of the disease, were given additional treatment with either antilymphocyte globulin (ALG) (seven patients), thoracic duct drainage (TDD) (five patients) or a combination of both (eight patients). Four of the seven patients treated with the addition of ALG showed remarkable improvement which has lasted little improvement. In the eight patients receiving both had severe allergic reactions to ALG which prevented adequate dosage. TDD alone was performed in patients sensitive to ALG. These five patients showed little improvement. In the eight patients receiving both ALG and TDD there was marked improvement in four patients which has again lasted several years. The main side effect of ALG therapy is allergic reactions. Major infections or tumour formation did not occur in any patients.

摘要

相似文献

1
Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis.
Postgrad Med J. 1976;52(5 Suppl):123-30.
2
Antilymphocyte globulin and adrenal steroids in the treatment of multiple sclerosis: short report based on seven cases.抗淋巴细胞球蛋白与肾上腺皮质类固醇治疗多发性硬化症:基于7例的简短报告
Boll Ist Sieroter Milan. 1979 Sep 30;58(4):339-43.
3
[Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)].
MMW Munch Med Wochenschr. 1977 Sep 2;119(35):1111-4.
4
Proceedings: Immunosuppressive treatment of multiple sclerosis with ALG and/or thoracic duct drainage.
Neurology. 1975 May;25(5):490.
5
[Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].[使用抗淋巴细胞血清、硫唑嘌呤和泼尼松联合治疗进展型和重症多发性硬化症。临床和生物学结果。与仅用硫唑嘌呤和泼尼松治疗的对照组比较。4年随访]
Rev Neurol (Paris). 1987;143(2):98-107.
6
[Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
MMW Munch Med Wochenschr. 1974 Nov 29;116(48):2105-12.
7
[Chromosomal aberrations in peripheral lymphocytes of patients with multiple sclerosis (author's transl)].
Dtsch Med Wochenschr. 1975 Oct 3;100(40):2028-34. doi: 10.1055/s-0028-1106496.
8
[Treatment of multiple sclerosis with antilymphocyte serum: results of a pilot study on 50 patients followed-up over a 4-year period (author's transl)].抗淋巴细胞血清治疗多发性硬化症:对50例患者进行4年随访的初步研究结果(作者译)
Rev Neurol (Paris). 1979 Jun;135(5):389-400.
9
[Therapeutic effect of antithymocyte/antilymphocyte globulin on severe aplastic anemia and therapy-related complications].抗胸腺细胞/抗淋巴细胞球蛋白对重型再生障碍性贫血及治疗相关并发症的治疗作用
Zhongguo Dang Dai Er Ke Za Zhi. 2006 Dec;8(6):479-81.
10
Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders.胸导管引流、抗淋巴细胞球蛋白、硫唑嘌呤及可的松联合应用达到“最大免疫抑制”对某些神经系统疾病的影响。
Proc R Soc Med. 1972 Jun;65(6):531-5. doi: 10.1177/003591577206500615.

引用本文的文献

1
Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.硫唑嘌呤治疗多发性硬化症——一项关于其疗效的3年对照研究
J Neurol. 1980;223(2):97-117. doi: 10.1007/BF00313173.
2
The evidence justifying immunosuppression therapy in multiple sclerosis.支持在多发性硬化症中进行免疫抑制治疗的证据。
Proc R Soc Med. 1977 Dec;70(12):871-4. doi: 10.1177/003591577707001214.